Canaccord Genuity Group Inc. (TSX:CF)

Canada flag Canada · Delayed Price · Currency is CAD
12.13
-0.12 (-0.98%)
May 15, 2026, 4:00 PM EST
Market Cap1.22B +48.7%
Revenue (ttm)1.95B +22.7%
Net Income-216.70M
EPS-2.20
Shares Out100.44M
PE Ration/a
Forward PE9.82
Dividend0.34 (2.80%)
Ex-Dividend DateFeb 27, 2026
Volume115,502
Average Volume95,324
Open12.29
Previous Close12.25
Day's Range12.00 - 12.29
52-Week Range8.70 - 13.82
Beta1.72
RSI49.00
Earnings DateJun 5, 2026

About Canaccord Genuity Group

Canaccord Genuity Group Inc., a full-service financial services company, provides investment products, and investment banking and brokerage services to institutional, corporate, and private clients. It operates in two segments, Canaccord Genuity Capital Markets and Canaccord Genuity Wealth Management. The Canaccord Genuity Capital Markets segment offers investment banking, advisory, research, merger and acquisition, sales, and trading services. The Canaccord Genuity Wealth Management segment provides wealth management solutions, and brokerage a... [Read more]

Sector Financials
Founded 1950
Employees 3,006
Stock Exchange Toronto Stock Exchange
Ticker Symbol CF
Full Company Profile

Financial Performance

In fiscal year 2025, Canaccord Genuity Group's revenue was 1.64 billion, an increase of 18.10% compared to the previous year's 1.39 billion. Losses were -28.91 million, 17.6% more than in 2024.

Financial Statements

News

QuantumCore to Present at Canaccord Genuity Virtual Quantum Symposium

Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - QuantumCore Ltd. (CSE: QNCR) ("QuantumCore" or the "Company"), a developer of advanced quantum infrastructure technologies, today announced its parti...

14 days ago - Newsfile Corp

BLUENERGIES ANNOUNCES FINANCIAL ADVISORY AGREEMENTS WITH HAYWOOD SECURITIES INC. AND CANACCORD GENUITY CORP.

TSXV: BLU | OTCQX: BLUGF VANCOUVER, BC, April 16, 2026 /PRNewswire/ - BluEnergies Ltd. (TSXV: BLU) ("BLU" or the "Company") announces it has entered into new strategic advisory services agreements (th...

4 weeks ago - PRNewsWire

Canaccord Genuity announces $80M settlement with U.S. agencies

Canaccord Genuity (CCORF) announced that its U.S. broker-dealer subsidiary has entered into final settlement agreements with the Securities and Exchange Commission, the Financial Industry Regulatory A...

2 months ago - TheFly

Canaccord Genuity price target raised to C$16 from C$14 at TD Securities

TD Securities analyst Graham Ryding raised the firm’s price target on Canaccord Genuity (CCORF) to C$16 from C$14 and keeps a Buy rating on the shares.

3 months ago - TheFly

CANACCORD GENUITY GROUP INC. BOLSTERS ITS CAPITAL MARKETS ADVISORY CAPABILITY WITH ACQUISITION OF LEADING ADVISOR TO THE RENEWABLE ENERGY SECTOR

TORONTO, Jan. 14, 2026 /PRNewswire/ - Canaccord Genuity Group Inc. (TSX: CF) (the "Company" or "Canaccord Genuity") is pleased to announce that through its U.S. capital markets business it has acquire...

4 months ago - PRNewsWire

Canaccord Genuity price target raised to C$14 from C$12 at TD Securities

TD Securities analyst Graham Ryding raised the firm’s price target on Canaccord Genuity (CCORF) to C$14 from C$12 and keeps a Buy rating on the shares.

6 months ago - TheFly

EBR Systems to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world's only left ventricular wireless cardiac pacing device for heart failure, today announced that management will be particip...

6 months ago - Business Wire

Octave Bioscience to Participate in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that is delivering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseas...

6 months ago - Business Wire

Canaccord confirms strategic review of British wealth unit, says no deal assured

Canaccord Genuity said on Friday it is evaluating options for its British wealth management business and had met with potential counterparties.

7 months ago - Reuters

Exclusive: Canaccord Genuity in early talks over possible sale of British wealth arm, sources say

Canadian financial services group Canaccord Genuity has been sounding out potential bidders, including CVC and Advent, for its British wealth arm, two people with knowledge of the matter told Reuters.

7 months ago - Reuters

TD Securities upgrades Canaccord Genuity on constructive wealth business view

As previously reported, TD Securities analyst Graham Ryding upgraded Canaccord Genuity (CCORF) to Buy from Hold with a price target of C$12, up from C$10, citing a more constructive view…

9 months ago - TheFly

Canaccord Genuity upgraded to Buy from Hold at TD Securities

TD Securities analyst Graham Ryding upgraded Canaccord Genuity (CCORF) to Buy from Hold with a price target of C$12, up from C$10.

9 months ago - TheFly

TMX Group CFO David Arnold to Present at the Canaccord Genuity 45th Annual Growth Conference

Toronto, Ontario--(Newsfile Corp. - July 29, 2025) - TMX Group CFO David Arnold will present at the Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13, 2025 from 1:00 p.m. to 1:25...

10 months ago - Newsfile Corp

CMG to Participate in the Canaccord Genuity 45th Annual Growth Conference

CALGARY, Alberta, July 29, 2025 (GLOBE NEWSWIRE) -- Computer Modelling Group Ltd. (“CMG” or the “Company”) (TSX: CMG) is pleased to announce that it will participate in the upcoming Canaccord Genuity ...

10 months ago - GlobeNewsWire

Tesla's stock driven by robotaxi excitement, says Canaccord Genuity's George Gianarikas

Canaccord Genuity's George Gianarikas and CNBC's Phil LeBeau discuss Tesla's latest deliveries data, the robotaxi story and much more.

11 months ago - CNBC Television

Canaccord Genuity upgraded to Buy from Market Perform at Cormark

Cormark upgraded Canaccord Genuity (CCORF) to Buy from Market Perform with a C$11.25 price target

1 year ago - TheFly

Spine BioPharma, Inc. to Present at the Canaccord Genuity 2025 Musculoskeletal Conference

NEW YORK--(BUSINESS WIRE)--Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced that Chief Executive ...

1 year ago - Business Wire

IDEX Metals Engages Canaccord Genuity and Red Cloud to Lead Subscription Receipt Financing

Not for distribution to U.S. news wire services or for dissemination in the United States

1 year ago - GlobeNewsWire

Canaccord Genuity downgraded to Hold at TD Securities on elevated expenses

As previously reported, TD Securities downgraded Canaccord Genuity (CCORF) to Hold from Buy with a price target of C$10, down from C$12, after quarterly results were below the firm’s forecast…

1 year ago - TheFly

Canaccord Genuity downgraded to Hold from Buy at TD Securities

TD Securities downgraded Canaccord Genuity (CCORF) to Hold from Buy with a price target of C$10, down from C$12.

1 year ago - TheFly

We're at the beginning of an 'energy supercycle,' says Canaccord Genuity's George Gianarikas

George Gianarikas, Canaccord Genuity senior analyst, joins CNBC's 'The Exchange' to discuss why he's anticipating major moves in energy stocks.

1 year ago - CNBC Television

TSX / Canaccord Genuity International Oil & Gas Investor Day Opens the Market

Toronto, Ontario--(Newsfile Corp. - December 11, 2024) - Representatives from Canaccord Genuity Group Inc. (TSX: CF) (Canaccord Genuity), joined Berk Sumen, Managing Director, Company Services, Toront...

1 year ago - Newsfile Corp

Canaccord Genuity price target raised to C$13 from C$11 at Raymond James

Raymond James raised the firm’s price target on Canaccord Genuity (CCORF) to C$13 from C$11 and keeps a Strong Buy rating on the shares.

1 year ago - TheFly

Revolo Announces Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference

GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics Limited (“Revolo”) today announced that President and Chief Executive Officer, Woody Bryan, Ph...

1 year ago - GlobeNewsWire

Converge Technology Solutions Announces Participation in the Canaccord Genuity 44th Annual Growth Conference

TORONTO and GATINEAU, QC, Aug. 6, 2024 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or the "Company") (TSX: CTS) is pleased to announce its participation in the Canaccord Genuity 44t...

1 year ago - PRNewsWire